Role of Kynurenine pathway and its metabolites in mood disorders: A systematic review and meta-analysis of clinical studies
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
HIGHLIGHTSDecreased levels of kynurenine was found in unipolar depression vs. healthy controls.No significant differences were found in tryptophan levels or kynurenine/tryptophan ratios in patients with unipolar or bipolar disorder vs. healthy controls. ABSTRACT Activation of the kynurenine pathway is one of the described mechanisms by which inflammation can induce depression. It involves multiple pathways including interference with the bioavailability of tryptophan central to the synthesis of the neurotransmitter serotonin. In this systematic review, we examine the relationship between kynurenine metabolites (kynurenine, kynurenic acid, tryptophan, quinolinic acid, the ratio of kynurenine and tryptophan) and mood disorders by conducting a meta‐analysis. Fifty‐six studies were identified, 21 met inclusion criteria and 14 were deemed suitable (9 investigating unipolar depression and 5 bipolar disorder). We found decreased levels of kynurenine in unipolar major depression vs. healthy controls but studies were significantly heterogeneous in nature. No significant differences were found in tryptophan levels or kynurenine/tryptophan ratios. Kynurenine metabolites are likely to play a role in major depression but an exact etiological role in mood disorder seem complex and requires further research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
Self-citationWhiteford, H. A., Degenhardt, L., Rehm, J., Baxter, A. J., Ferrari, A. J., Erskine, H. E., Charlson, F. J., Norman, R. E., Flaxman, A. D., Johns, N., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61611-6 · Cited by 6,006
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848 · cited 1×
“Elevated peripheral pro-inflammatory markers have been associated with depression and bipolar disorders (Miller et al., 2009; Strawbridge et al., 2015).”
The Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010)
Greenberg, P. E., Fournier, A.-A., Sisitsky, T., Pike, C. T., & Kessler, R. C. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09298 · Cited by 1,779
Collaborative care for patients with depression and chronic illnesses
Katon, W. J., Lin, E. H. B., Von Korff, M., Ciechanowski, P., Ludman, E. J., Young, B., Peterson, D., Rutter, C. M., McGregor, M., & McCulloch, D. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003955 · Cited by 1,697
Microglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543 · cited 1×
“Activated microglia release pro-inflammatory cytokines such as IL-1, IL-6, TNF, and prostaglandins (Perry et al., 2010).”
Kynurenines in the mammalian brain: when physiology meets pathology
Schwarcz, R., Bruno, J. P., Muchowski, P. J., & Wu, H.-Q. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3257 · Cited by 1,530 · cited 1×
“Downstream of IDO1, two separate metabolic pathways transform kynurenine (KYN), the main metabolite of TRP, to the neuroprotective kynurenic acid (KYNA) in astrocytes or the neurotoxic 3-hydroxykynurenine (3-HK) and quinolinic acid (QUIN) in microglia (Müller and Schwarz, 2008; Schwarcz et al., 2012).”
Kynurenines: Tryptophan’s metabolites in exercise, inflammation, and mental health
Cervenka, I., Agudelo, L. Z., & Ruas, J. L. (2017) · Science · doi:10.1126/science.aaf9794 · Cited by 1,382 · cited 2×
“Other putative factors shown to affect levels of kynurenine metabolites include antidepressants and other treatments like electroconvulsive therapy (Cervenka et al., 2017).”
Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis
Barth, J., Schumacher, M., & Herrmann-Lingen, C. (2004) · Psychosomatic Medicine · doi:10.1097/01.psy.0000146332.53619.b2 · Cited by 1,358 · cited 1×
“They are a major public health concern due to their chronicity, risk of suicide and high co-morbidity with other disabling diseases such as diabetes and cardiovascular diseases (Angst et al., 2013; Barth et al., 2004; Fornaro et al., 2017; Greenberg et al., 2015; Hesdorffer et al., 2000; Knol et al., 2006; Simon, 2003…”
Inflammation-associated depression: From serotonin to kynurenine
Dantzer, R., O’Connor, J. C., Lawson, M. A., & Kelley, K. W. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.09.012 · Cited by 726
Self-citationInflammation and clinical response to treatment in depression: A meta-analysis
Strawbridge, R., Arnone, D., Danese, A., Papadopoulos, A., Herane Vives, A., & Cleare, A. J. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.06.007 · Cited by 666
Self-citationRaison, C. L., Dantzer, R., Kelley, K. W., Lawson, M. A., Woolwine, B. J., Vogt, G., Spivey, J. R., Saito, K., & Miller, A. H. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.116 · Cited by 630 · cited 1×
“Raison et al. 2010 (Raison et al., 2010) is the only study that evaluated the effect of IFNalpha/ribavirin therapy on both plasma and cerebrospinal fluid (CSF) levels of TRP, KYN and QUIN as well as the KYN/TRP ratio in HCV patients (n=16).”
BackgroundSelf-citationArnone, D., McIntosh, A. M., Ebmeier, K. P., Munafò, M. R., & Anderson, I. M. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.05.003 · Cited by 495
Self-citationInterferon-alpha–induced changes in tryptophan metabolism
Capuron, L., Neurauter, G., Musselman, D. L., Lawson, D. H., Nemeroff, C. B., Fuchs, D., & Miller, A. H. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00173-2 · Cited by 493
Zaza, S., Wright-De Agüero, L. K., Briss, P. A., Truman, B. I., Hopkins, D. P., Hennessy, M. H., Sosin, D. M., Anderson, L., Carande-Kulis, V. G., Teutsch, S. M., et al. (2000) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(99)00122-1 · Cited by 464
Walker, A. K., Budac, D. P., Bisulco, S., Lee, A. W., Smith, R. A., Beenders, B., Kelley, K. W., & Dantzer, R. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.71 · Cited by 432
Self-citationConnecting inflammation with glutamate agonism in suicidality
Erhardt, S., Lim, C. K., Linderholm, K. R., Janelidze, S., Lindqvist, D., Samuelsson, M., Lundberg, K., Postolache, T. T., Träskman-Bendz, L., Guillemin, G. J., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.248 · Cited by 345 · cited 1×
“…health concern due to their chronicity, risk of suicide and high co-morbidity with other disabling diseases such as diabetes and cardiovascular diseases (Angst et al., 2013; Barth et al., 2004; Fornaro et al., 2017; Greenberg et al., 2015; Hesdorffer et al., 2000; Knol et al., 2006; Simon, 2003).”
Savitz, J., Drevets, W. C., Smith, C. M., Victor, T. A., Wurfel, B. E., Bellgowan, P. S., Bodurka, J., Teague, T. K., & Dantzer, R. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.194 · Cited by 272
Self-citationPlasma kynurenine levels are elevated in suicide attempters with major depressive disorder
Sublette, M. E., Galfalvy, H. C., Fuchs, D., Lapidus, M., Grunebaum, M. F., Oquendo, M. A., John Mann, J., & Postolache, T. T. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.05.002 · Cited by 250 · cited 6×
“…nine studies available (Baranyi et al., 2017; Bradley et al., 2015; Dahl et al., 2015; Krause et al., 2017; Meier et al., 2016; Quak et al., 2014; Sublette et al., 2011; Umehara et al., 2017; Wood et al., 1978) showed a significant reduction in kynurenine in MDD vs. healthy controls with an…”
InfluentialSelvaraj, S., Arnone, D., Cappai, A., & Howes, O. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.06.005 · Cited by 223 · cited 1×
“0 (Stata Corp, College Station, Texas) supplemented by ‘Metan’ software downloadable from the Centre for Statistics in Medicine, Oxford, UK as previously described (Arnone et al., 2009, 2012; Lavagnino et al., 2016; Selvaraj et al., 2014).”
Self-citationPlasma L -Tryptophan Concentration in Major Depressive Disorder: New Data and Meta-Analysis
Ogawa, S., Fujii, T., Koga, N., Hori, H., Teraishi, T., Hattori, K., Noda, T., Higuchi, T., Motohashi, N., & Kunugi, H. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13r08908 · Cited by 183
Meier, T. B., Drevets, W. C., Wurfel, B. E., Ford, B. N., Morris, H. M., Victor, T. A., Bodurka, J., Teague, T. K., Dantzer, R., & Savitz, J. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.11.003 · Cited by 175
Self-citationArnone, D., Mumuni, A. N., Jauhar, S., Condon, B., & Cavanagh, J. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.04.016 · Cited by 150 · cited 1×
“This is in agreement with the therapeutic role of ketamine in the treatment of MDD and the central role played by astrocytes and microglia in glutamine/glutamate dysregulation (Arnone et al., 2015), potentially enhancing neurotoxicity of quinolinic acid (Dantzer and Walker, 2014).”
Self-citationThe role of the kynurenine pathway in suicidality in adolescent major depressive disorder
Bradley, K. A. L., Case, J. A. C., Khan, O., Ricart, T., Hanna, A., Alonso, C. M., & Gabbay, V. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.03.031 · Cited by 115 · cited 4×
“c) Kynurenine/tryptophan ratio Six studies were included in this analysis (Baranyi et al., 2017; Bradley et al., 2015; Dahl et al., 2015; Meier et al., 2016; Quak et al., 2014; Sublette et al., 2011) and indicated a trend towards an increase in the kynurenine/tryptophan ratio in MDD with an effect size of 0.”
InfluentialQuak, J., Doornbos, B., Roest, A. M., Duivis, H. E., Vogelzangs, N., Nolen, W. A., Penninx, B. W. J. H., Kema, I. P., & de Jonge, P. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.03.013 · Cited by 98 · cited 5×
“Fourteen studies were identified and eleven met inclusion criteria (Baranyi et al., 2017; Bradley et al., 2015; Dahl et al., 2015; Krause et al., 2017; Meier et al., 2016; Myint et al., 2013, 2007b; Neupane et al., 2015; Quak et al., 2014; Savitz et al., 2015b; Sorgdrager et al., 2017; Sublette et al., 2011; Umehara e…”
InfluentialTryptophan Metabolism and Immunogenetics in Major Depression: A Role for Interferon-γ Gene
Myint, A. M., Bondy, B., Baghai, T. C., Eser, D., Nothdurfter, C., Schüle, C., Zill, P., Müller, N., Rupprecht, R., & Schwarz, M. J. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.04.003 · Cited by 74 · cited 1×
“(Table 1) having excluded the study by Myint and colleagues, 2013 (Myint et al., 2013)”
Cited by
Marx, W., McGuinness, A. J., Rocks, T., Ruusunen, A., Cleminson, J., Walker, A. J., Gomes-da-Costa, S., Lane, M., Sanches, M., Diaz, A. P., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00951-9 · Cited by 322
Central and Peripheral Inflammation Link Metabolic Syndrome and Major Depressive Disorder
Chan, K. L., Cathomas, F., & Russo, S. J. (2019) · Physiology · doi:10.1152/physiol.00047.2018 · Cited by 227
“However, a meta-analysis of nine studies found that circulating kynurenine levels decrease in patients with unipolar depression compared with healthy controls (6), indicating that further research is required to elucidate the role of kynurenine in depression.”
BackgroundLasselin, J., Schedlowski, M., Karshikoff, B., Engler, H., Lekander, M., & Konsman, J. P. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.05.001 · Cited by 165
“Research further suggests that inflammatory pathways may play a role in mood disorders (Arnone et al., 2018; Miller and Raison, 2016), and a recent meta-analysis suggests that inflammatory processes alter brain functions, predisposing patients with inflammatory diseases to mood disorders (Kraynak et al.”
Peripheral and central kynurenine pathway abnormalities in major depression
Paul, E. R., Schwieler, L., Erhardt, S., Boda, S., Trepci, A., Kämpe, R., Asratian, A., Holm, L., Yngve, A., Dantzer, R., et al. (2022) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2022.01.002 · Cited by 134
Self-citationEffects of inflammation on the kynurenine pathway in schizophrenia—a systematic review
Pedraz-Petrozzi, B., Elyamany, O., Rummel, C., & Mulert, C. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1721-z · Cited by 119
Metadata
- Authors
- Arnone, D., Saraykar, S., Salem, H., Teixeira, A. L., Dantzer, R., & Selvaraj, S.
- Venue
- Neuroscience & Biobehavioral Reviews
- Publisher
- Elsevier BV
- Published
- 2018-09
- Volume
- 92
- Pages
- 477-485
- ISSN
- 0149-7634 (ISSN-L)
- OpenAlex
- W2808861689
- Cited by
- 130
- References
- 26
- FWCI
- 1.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.